SERAFIN, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 2.665
EU - Europa 2.583
AS - Asia 2.141
SA - Sud America 265
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 26
OC - Oceania 2
Totale 7.732
Nazione #
US - Stati Uniti d'America 2.576
SE - Svezia 1.782
SG - Singapore 670
CN - Cina 663
HK - Hong Kong 255
IT - Italia 250
VN - Vietnam 207
BR - Brasile 204
GB - Regno Unito 162
KR - Corea 128
FI - Finlandia 116
RU - Federazione Russa 84
BD - Bangladesh 67
FR - Francia 52
DE - Germania 47
CA - Canada 45
ID - Indonesia 40
LT - Lituania 23
AR - Argentina 19
EC - Ecuador 13
IN - India 13
MX - Messico 13
TR - Turchia 12
IQ - Iraq 11
VE - Venezuela 9
CO - Colombia 8
JM - Giamaica 8
NL - Olanda 8
IL - Israele 7
JP - Giappone 7
PH - Filippine 7
LU - Lussemburgo 6
PK - Pakistan 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
BE - Belgio 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
PL - Polonia 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
UA - Ucraina 5
UZ - Uzbekistan 5
AT - Austria 4
CH - Svizzera 4
CR - Costa Rica 4
HN - Honduras 4
MY - Malesia 4
AL - Albania 3
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
EG - Egitto 3
ES - Italia 3
IE - Irlanda 3
JO - Giordania 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
SV - El Salvador 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BY - Bielorussia 2
ET - Etiopia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SO - Somalia 1
TN - Tunisia 1
Totale 7.681
Città #
Stockholm 1.770
Santa Clara 505
Hefei 424
Ashburn 391
Singapore 364
San Jose 314
Hong Kong 247
Council Bluffs 172
Seoul 126
Helsinki 103
London 83
Ho Chi Minh City 81
Los Angeles 65
The Dalles 56
Hanoi 48
New York 47
Beijing 46
Boardman 43
Chicago 38
Lauterbourg 35
Woodbridge 32
Jakarta 31
Moscow 31
Dallas 30
Modena 29
Buffalo 27
Milan 27
Houston 25
Kent 25
Fairfield 23
Salt Lake City 19
Bologna 18
Chandler 17
Shanghai 16
Southend 16
São Paulo 15
North Bergen 14
Portsmouth 14
Wilmington 14
Padova 13
Atlanta 12
Munich 12
Seattle 12
Indianapolis 11
Jacksonville 11
Nyköping 11
Phoenix 11
Brooklyn 10
Haiphong 10
Lappeenranta 10
Nuremberg 10
Redondo Beach 10
Toronto 10
Kilburn 9
Orem 9
San Francisco 9
Cambridge 8
Columbus 8
Elk Grove Village 8
Saint Augustine 8
Tampa 8
Brasília 7
Glasgow 7
Rio de Janeiro 7
Rome 7
San Diego 7
Tokyo 7
Torre del Greco 7
Vilnius 7
Belo Horizonte 6
Guangzhou 6
Guayaquil 6
Luxembourg 6
Montreal 6
Newark 6
Paris 6
Philadelphia 6
Reggio Emilia 6
San Antonio 6
Bari 5
Brantford 5
Curitiba 5
Da Nang 5
Denver 5
Memphis 5
Miano 5
Oklahoma City 5
Pittsburgh 5
Sofia 5
Surrey 5
Baghdad 4
Boston 4
Changsha 4
Cleveland 4
Davenport 4
Dearborn 4
Dhaka 4
Falls Church 4
Figino 4
Formigine 4
Totale 5.812
Nome #
A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features 1.935
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 323
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 201
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 199
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion 183
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 180
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 173
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 171
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 169
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML 169
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 164
CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability 161
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes 161
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 153
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 152
NUP214-ABL1 fusion in childhood T-ALL 152
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation 150
NOTCH3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS 150
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 143
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 140
A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions 138
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 136
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia 135
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 135
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 131
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia 131
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia 129
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia 126
Correction: A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia (Leukemia, (2023), 10.1038/s41375-023-02096-4) 124
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 124
Notch3 signalling promotes tumour growth in colorectal cancer 123
A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia 122
Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells 120
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 119
Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts 118
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia 115
Modulation of microRNA expression in human T-cell development: Targeting of NOTCH3 by miR-150 114
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 108
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 108
Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer 101
null 35
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway 11
Totale 7.732
Categoria #
all - tutte 30.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 0 0 5 9 8 3 7 6 14 5
2022/202368 8 5 6 2 5 8 0 8 12 1 7 6
2023/2024372 1 1 41 62 59 15 32 53 12 23 27 46
2024/20251.631 58 11 9 78 370 228 32 109 229 91 212 204
2025/20264.585 230 187 311 287 321 123 425 92 2.015 246 227 121
2026/2027885 84 170 240 355 36 0 0 0 0 0 0 0
Totale 7.732